薬剤比較
Insulin Regular Human vs Rosiglitazone
Compare regular insulin vs rosiglitazone for type 2 diabetes treatment. Insulin is injectable short-acting, rosiglitazone is oral with CV and HF risks.
このページには比較できる項目がありません。
臨床的背景
This comparison arises for type 2 diabetes patients considering thiazolidinedione therapy versus starting insulin.
結論
Insulin is more versatile and preferred for broader use while rosiglitazone has significant safety limitations.
すべての薬剤比較